nemo II Inhibitors
Nemo II inhibitors refer to a category of chemical compounds specifically designed to target and modulate the activity of a protein known as Nemo-like kinase II, often abbreviated as Nemo II. Nemo-like kinases are a subgroup of protein kinases within the serine/threonine protein kinase family, and they are involved in various cellular processes, including cell signaling, gene expression regulation, and cell cycle control. The precise role of Nemo II and its inhibitors in cellular processes is an area of ongoing research in molecular biology and cell biology.
These inhibitors are typically small molecules or compounds designed to interact with Nemo II, influencing its kinase activity or its interactions with specific substrates, co-factors, or regulatory proteins. By doing so, Nemo II inhibitors may impact cellular signaling pathways and molecular processes that are dependent on the activity of Nemo II. Research into Nemo II inhibitors is vital for gaining insights into the functions and regulatory mechanisms of this kinase and for understanding its role in fundamental cellular processes. Additionally, this research may contribute to a deeper understanding of cell signaling networks and implications in cellular physiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent non-selective kinase inhibitor that may inhibit a broad range of kinases, including NLK, by competing with ATP for binding to the catalytic kinase domain. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor that could indirectly affect kinase signaling pathways, potentially influencing NLK activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A selective inhibitor of c-Jun N-terminal kinase (JNK), which might modulate downstream targets and indirectly affect NLK-related signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A selective inhibitor of p38 MAPK that could impact kinase signaling cascades and indirectly alter the activity of kinases such as NLK. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of mitogen-activated protein kinase kinase (MEK), which may perturb signaling pathways that intersect with NLK function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of the mTOR pathway, which regulates cell growth and proliferation, and may have downstream effects on various kinases, potentially including NLK. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
An inhibitor of PI3K, which could have indirect effects on kinase signaling and potentially influence NLK signaling pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A selective inhibitor of Src family kinases, which could have broader effects on tyrosine kinase-related signaling pathways that may intersect with NLK activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A Raf kinase inhibitor that also inhibits several receptor tyrosine kinases, potentially affecting signaling pathways that intersect with or regulate NLK. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
An inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, which might indirectly affect kinase-dependent signaling pathways involving NLK. | ||||||